BioSpace News Archive

Sight Sciences, Inc. today announced that data from clinical studies of the OMNI ® Surgical System will be presented at the 2022 American Glaucoma Society (AGS) Annual Meeting.

Daré Bioscience, Inc. announced that members of its management team will participate in the following conferences.

Ceapro Inc. announced the appointment of leading international pharmaceutical industry executive, Ronnie Miller, to its Board of Directors.

OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders, today announced that the company will present at the upcoming Festival of Biologics World Immunotherapy Congress and World Antibody Congress taking place March 9 - 11, 2022 in San Diego, California.

Caraway Therapeutics today announced the appointment of David Clapham, MD, PhD, to the company’s Scientific Advisory Board (SAB).

Establishment Labs to Present at the Cowen 42nd Annual Health Care Conference.

OrthoGrid® Systems, Inc., is pleased to announce the OrthoGrid Hip AI application. Powered by artificial intelligence and machine learning, our Hip AI platform is the world’s first-ever intraoperative hip replacement navigation system.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced its participation in three in-person medical conferences and one virtual investor panel in March.

TC Biopharm announced today that it will host a corporate update call for interested parties on Tuesday, March 8, 2022 at 9:00 am ET.

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report fourth quarter and year-end 2021 results on Wednesday, March 9, 2022.